|
[1]
|
Rambaldi PF,Mansi L,Procaini E,et al.Breast can-cer detestion with 99Tcm-tetrofosmin[J].Clin Nucl Med,1995,20:703-705. |
|
[2]
|
Mansi L,Rambaldi PF,Cuccurullo V,et al.Diagnos-tic and prognostic role of 99Tcm-tetrofosmin in breast cancer[J].Q J Nucl Med,1997,41:239-250. |
|
[3]
|
Arbab AS,Koizumi K,Toyama K,et al.Uptake of technetium-99m-tetrofosmin,technetium-99m-MIBI and thallium-201 in tumor cell lines[J].J Nucl Med,1996,37:1551-1556. |
|
[4]
|
De Jong M,Bernard BF,Breeman WAP,et al.Com-parison of uptake of 99Tcm-MIBI,99Tcm-tetrofosmin and 99Tcm-Q12 into human breast cancer cell lines[J].Eur JNucl M ed,1996,23:1361-1366. |
|
[5]
|
Ballinger JR,Bannerman J,Boxen I,et al.Tech-netium-99m-tetrofosmin as a substrate for P-glycopro-tein:in vitro studies in multidrugresistant breast tu-mor cells[J].J Nucl Med,1996,37:1578-1582. |
|
[6]
|
Higley B,Smith FW,Smith T,et al.Technetium-99m-1,2-bis[bis (2-ethoxyethyl) phosphino] ethane:hu-man biodistribution,dosimetry and safety of a new myocardial perfusion imaging agent[J].J Nucl Med,1993,34:30-38. |
|
[7]
|
Mansi L,Rambaldi PF,Procaccini E,et al.Scinti-mammography with technetium-99m-tetrofosmin in the diagnosis of breast cancer and lymph node metas-tases[J].Eur J Nucl Med,1996,23:932-939. |
|
[8]
|
Batista JF,Solano ME,Oliva JP,et al.Usefulness of 99Tcm-tetrofosmin scintimammography in palpable breast tumours[J].Nucl Med Commun,1997,18:338-340. |
|
[9]
|
Buscombe JR,Cwikla JB,Thakrar DS,et al.Prone SPET scintimammography[J].Nucl Med Commun,1999,20:237-245. |
|
[10]
|
Adalet I,Demirkol MO,Muslumanoglu M,et al.99Tcm-tetrofosmin scintigraphy in the evaluation of pal-pable breast masses[J].Nucl Med Commun,1997,18:118-121. |
|
[11]
|
Akcay MN,Akin Y,Karabag B,et al.99Tcm-tetrofos-min in breast carcinoma and axillary Iymph node metastases:a comparative study with 99Tcm-MIBI[J].Clin Nucl Med,1997,22:832-834. |
|
[12]
|
Takayame T,Kinuya S,Sugiyama M,et al.99Tcm-tetrofosmin scintimammography in palpable breast tu-mours[J].Ann Nucl Med,1998,12:293-296. |
|
[13]
|
Lacic M,Bokulic T,Lukac J,et al.Bone marrow im-munoscintigraphy for the detection of skeletal metas-tases in patients with breast cancer[J].Nucl Med Commun,1999,20:135-143. |
|
[14]
|
Keshtgar M RS,Ell PJ.Sentinel lymph node detection and imaging[J].Eur J Nucl Med,1999,26:57-67. |
|
[15]
|
Kabasakal L,Halac M,Nisli C,et al.The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi[J].Clin Nucl Med,2000,25:20-23. |
|
[16]
|
Yutani K,Tatsumi M,Shiba E,et al.Comparison of dual-head coincidence gamma camera FDG PET in de-tection of breast cancer and axillary lymph node metas-tasis[J].JNucl Med,1999,40:1003-1008. |
|
[17]
|
Rostom AY,Powe J,Kandil A,et al.Positron emis-sion tomography in breast cancer:a clinico-pathologi-cal correlation of results[J].Br J Radiol,1999,72:1064-1068. |
|
[18]
|
Bleckmann C,Dose J,Bohuslavizki KH,et al.Effect of attenuation correction on lesion detectability in FDG PET of breast cancer[J].JNucl Med,1999,40:2021-2024. |
|
[19]
|
Amano S,Inoue T,Tomiyoshi K,et al.In vivo com-parison of PET and SPECT radiopharmaceuticals in detecting breast cancer[J].J Nucl Med,1998,39:1424-1427. |
|
[20]
|
Dehdashti F,Flanagan FL,Mortimer JE,et al.Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy[J].Eur J Nucl Med,1999,26:51-56. |
|
[21]
|
Fischer U,Kopka L,Grabbe E.Breast carcinoma:ef-fect of preoperative constrast-enhanced MR imaging on the therapeutic approach[J].Radiology,1999,213:881-888. |
|
[22]
|
Chen DR,Chang PF,Huang YL.Computer-aided di-agnosis applied to U S of solid breast nodules by using neural networks[J].Radiology,1999,213:407-412. |
|
[23]
|
Zonderland HM,Coerkamp E,Hermans J,et al.Di-agnosis of breast cancer of contribution of US as an ad-junct to mammography[J].Radiology,1999,213:413-422. |
DownLoad: